HomeZVSA • OTCMKTS
add
Zyversa Therapeutics Inc
Previous close
$0.14
Day range
$0.14 - $0.14
Year range
$0.11 - $1.95
Market cap
1.13M USD
Avg Volume
34.32K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.10M | -7.29% |
Net income | -19.81M | -724.80% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.10M | 7.29% |
Effective tax rate | 4.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 527.98K | 329.53% |
Total assets | 1.04M | -94.64% |
Total liabilities | 12.77M | 2.98% |
Total equity | -11.73M | — |
Shares outstanding | 8.10M | — |
Price to book | -0.10 | — |
Return on assets | -50.87% | — |
Return on capital | 187.02% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -19.81M | -724.80% |
Cash from operations | -1.41M | -129.09% |
Cash from investing | — | — |
Cash from financing | 1.86M | 201.63% |
Net change in cash | 455.89K | 13,171.97% |
Free cash flow | -1.24M | -367.20% |
About
Founded
2014
Headquarters
Website
Employees
7
